Robert Atchinson Calithera Biosciences, Inc

As of September 28, 2017


Robert Atchinson Net Worth

  • Net worth is estimated to be at least $3.12B
  • Owns at least 3,546,873 units of Calithera Biosciences, Inc stock
  • Sold an estimated value of $9.01M in the last 3 years at Calithera Biosciences, Inc

Robert Atchinson Trading

  • Largest purchase of shares was 800,000 units , worth over $8M on October 3, 2014
  • Largest sale of shares was 576,000 units , worth over $9.01M on September 28, 2017
  • In total has made about 8 transactions over 3 years
  • Usually trades in September, with the busiest year in 2015

ADAGE CAPITAL PARTNERS GP LLC, Adage Capital Partners LP, Adage Capital Advisors LLC, Robert Atchinson, Phillip Gross

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Robert Atchinson Mailing Address

  • Mailing address is 200 Clarendon Street 52nd Floor Boston MA 02116 MA

Calithera Biosciences, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Susan Molineaux, Ph.D. 2020 $569,250 $222,008 $2,813,619 $15,694 $3,620,571
Susan Molineaux, Ph.D. 2019 $550,000 $321,750 $1,322,802 $15,290 $2,209,842
Keith Orford, M.D., Ph.D. 2020 $455,400 $149,371 $772,366 $24,262 $1,401,399
Keith Orford, M.D., Ph.D. 2019 $440,000 $172,480 $447,718 $181,372 $1,241,570
Curtis C. Hecht 2020 $400,100 $131,233 $662,028 $9,299 $1,202,660
Curtis C. Hecht 2019 $380,000 $148,960 $396,841 $9,211 $935,012
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1496671/000119312521128983/d122933ddef14a.htm

Calithera Biosciences, Inc Insider Trading

  • The most recent transaction was 2,447 units sold on December 18, 2020 by Keith Orford worth over $14.68K
  • In the last 6 years, insiders at Calithera Biosciences, Inc sold an estimated value of $22.98M and bought an estimated value of $67.62M
  • The most active traders are Keith Orford, CHIEF MEDICAL OFFICER,  Christopher Molineaux, SR. VP,  and Susan Molineaux, PRESIDENT & CEO
  • Insider trading is most common in June, with the busiest year in 2019

Calithera Biosciences, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1